The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

Type: Package
Title: Bayesian Single-Arm Design with Survival Endpoints
Version: 0.1.1
Description: The proposed event-driven approach for Bayesian two-stage single-arm phase II trial design is a novel clinical trial design and can be regarded as an extension of the Simon’s two-stage design with the time-to-event endpoint. This design is motivated by cancer clinical trials with immunotherapy and molecularly targeted therapy, in which time-to-event endpoint is often a desired endpoint.
License: GPL-2
Encoding: UTF-8
NeedsCompilation: no
Packaged: 2021-05-03 03:22:23 UTC; chsu1
Author: Chia-Wei Hsu [aut, cre], Haitao Pan [aut], Jianrong Wu [aut]
Maintainer: Chia-Wei Hsu <Chia-Wei.Hsu@stjude.org>
Repository: CRAN
Date/Publication: 2021-05-04 06:30:16 UTC

Obtain design settings for one-stage Bayesian Single-Arm Phase II Trial with Time-to-Event Endpoints

Description

Obtain design parameters, type I error, power and operating characteristics of the Bayesian Single-Arm Phase II Trial Designs with Time-to-Event Endpoints (Wu et al. 2021). The exponential distribution is assumed for the survival time. The gamma prior is used here

Usage

optimal_OneStage(alphacutoff, powercutoff, S0,
                 x, ta, tf, a = 2, delta, ntrial,
                 complete = "partial", seed = 8232)

Arguments

alphacutoff

the desired type I error to be controlled

powercutoff

the desired power to be achieved

S0

the survival probability at timepoint x

x

the survival probability S0 at timepoint x

ta

accrual duration

tf

follow-up duration

a

shape parameter of prior distribution. The default value is a = 2

delta

hazard ratio

ntrial

the number of simulated trials

complete

whether output the full or partial information. The default value is complete = "partial". If want to show full results, it would be complete = "complete"

seed

the seed. The default value is seed = 8232

Value

optimal_OneStage() depending on the argument "complete", it returns a vector of partial information/complete information which includes:

partial information: (1) m: number of events of the whole design (2) n: number of patients of the whole design (3) k: total observation time of the whole design (4) typeI: type I error of the whole design (5) power: power of the whole design (6) ES1: expected sample size under alternative hypothesis (7) ES0: expected sample size under null hypothesis

full information: (1) eta: cutoff point of "Go" at final stage of analysis (2) zeta: cutoff point of "no-Go" at final stage of analysis (3) m: number of events of the whole design (4) n: number of patients of the whole design (5) k: total observation time of the whole design (6) typeI: type I error of the whole design (7) power: power of the whole design (8) ES1: expected sample size under alternative hypothesis (9) ES0: expected sample size under null hypothesis

Author(s)

Chia-Wei Hsu, Haitao Pan, Jianrong Wu

References

Jianrong Wu, Haitao Pan, Chia-Wei Hsu (2021). "Bayesian Single-Arm Phase II Trial Designs with Time-to-Event Endpoints." Pharmaceutical Statistics. Accepted

Examples


### Design 1

# H0 vs. H1: 17% vs. 40% (4-month PFS)
# that is, S0 = 0.17, and hazard ratio, e.g., delta = 0.517
# x = 4

optimal_OneStage(alphacutoff = 0.1, powercutoff = 0.8,
                 S0 = 0.17, x = 4, ta = 6, tf = 6,
                 delta = 0.517, ntrial = 10)

### Design 2

# H0 vs. H1: 17% vs. 30% (4-month PFS)
# that is, S0 = 0.17, and hazard ratio, e.g., delta = 0.679
# x = 4

optimal_OneStage(alphacutoff = 0.1, powercutoff = 0.8,
                 S0 = 0.17, x = 4, ta = 6, tf = 6,
                 delta = 0.679, ntrial = 10)

Obtain design settings for two-stage Bayesian Single-Arm Phase II Trial with Time-to-Event Endpoints

Description

Obtain design parameters, type I error, power and operating characteristics of the Bayesian Single-Arm Phase II Trial Designs with Time-to-Event Endpoints (Wu et al. 2021). The exponential distribution is assumed for the survival time. The gamma prior is used here

Usage

optimal_TwoStage(alphacutoff, powercutoff, S0, x,
                 ta, tf, a = 2, delta, frac = .5,
                 ntrial, complete = "partial", seed = 8232)

Arguments

alphacutoff

the desired type I error to be controlled

powercutoff

the desired power to be achieved

S0

the survival probability at timepoint x

x

the survival probability S0 at timepoint x

ta

accrual duration

tf

follow-up duration

a

shape parameter of prior distribution. The default value is a = 2

delta

hazard ratio

frac

a information fraction for interim analysis. The fefault value is frac = 0.5

ntrial

the number of simulated trials

complete

whether output the full or partial information. The default value is complete = "partial". If want to show full results, it would be complete = "complete"

seed

the seed. The default value is seed = 8232

Value

optimal() depending on the argument "complete", it returns a vector of partial information/complete information which includes:

partial information: (1) m1: number of events at stage 1 (2) n1: number of patients at stage 1 (3) k1: total observation time at stage 1 (4) m: number of events of the whole design (5) n: number of patients of the whole design (6) k: total observation time of the whole design (7) typeI: type I error of the whole design (8) power: power of the whole design (9) PET1: early stopping probabilites under alternative hypothesis (10) ES1: expected sample size under alternative hypothesis (11) PET0: early stopping probabilites under null hypothesis (12) ES0: expected sample size under null hypothesis

full information: (1) eta: cutoff point of "Go" at final stage of analysis (2) xi: cutoff point of "no-Go" at final stage of analysis (3) m1: number of events at stage 1 (4) n1: number of patients at stage 1 (5) k1: total observation time at stage 1 (6) m: number of events of the whole design (7) n: number of patients of the whole design (8) k: total observation time of the whole design (9) typeI: type I error of the whole design (10) power: power of the whole design (11) PET1: early stopping probabilites under alternative hypothesis (12) ES1: expected sample size under alternative hypothesis (13) PET0: early stopping probabilites under null hypothesis (14) ES0: expected sample size under null hypothesis

Author(s)

Chia-Wei Hsu, Haitao Pan, Jianrong Wu

References

Jianrong Wu, Haitao Pan, Chia-Wei Hsu (2021). "Bayesian Single-Arm Phase II Trial Designs with Time-to-Event Endpoints." Pharmaceutical Statistics. Accepted

Examples


### Design 1

# H0 vs. H1: 17% vs. 40% (4-month PFS)
# that is, S0 = 0.17, and hazard ratio, e.g., delta = 0.517
# x = 4

optimal_TwoStage(alphacutoff = 0.1, powercutoff = 0.8, S0 = 0.17,
                 x = 4, ta = 6, tf = 6, delta = 0.517, ntrial = 10)

### Design 2

# H0 vs. H1: 17% vs. 30% (4-month PFS)
# that is, S0 = 0.17, and hazard ratio, e.g., delta = 0.679
# x = 4

optimal_TwoStage(alphacutoff = 0.1, powercutoff = 0.8, S0 = 0.17,
                 x = 4, ta = 6, tf = 6, delta = 0.679, ntrial = 10)

Sum up transformed observation time for each patient

Description

Sum up transformed observation time for each patient to get U in order to determine the trial: (1) goes to second stage (2) stops for futility (3) declares the treatment is promising and warrants for further study in a large scale phase III trial (4) declares the treatment is unpromising and is not worth for further study.

Usage

tot_time(obs_time, S0, x)

Arguments

obs_time

a vector. Each element represents an observation time of the patient

S0

the survival probability at timepoint x

x

the survival probability S0 at timepoint x

Value

the function returns the total transformed observation time for all patients

Author(s)

Chia-Wei Hsu, Haitao Pan, Jianrong Wu

References

Jianrong Wu, Haitao Pan, Chia-Wei Hsu (2021). "Bayesian Single-Arm Phase II Trial Designs with Time-to-Event Endpoints." Pharmaceutical Statistics. Accepted

Examples

obs_time <- c(3.003, 11.987, 4.306, 2.561, 1.575, 0.329, 1.940,
              0.869, 7.481, 1.861, 7.279, 0.007, 6.485, 1.981,
              4.257, 0.967, 2.619, 0.040, 0.426, 4.628)
S0 <- 0.17
x <- 4
tot_time(obs_time = obs_time, S0 = S0, x = x)

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.